Topic Hub
17 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 17 of 17 clinical reviews.
A clinical review of the MK-677 (ibutamoren) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein pathways, pharmacodynamic risks, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewA clinical review of the MK-677 (ibutamoren) and bupropion drug interaction, covering CYP2D6 metabolism, seizure-threshold concerns, blood glucose effects, and monitoring recommendations.
Read clinical reviewCan you take MK-677 (ibutamoren) with clopidogrel? This physician-reviewed guide covers the CYP2C19-mediated interaction, antiplatelet efficacy concerns, monitoring parameters, and dose-adjustment strategies.
Read clinical reviewA clinician-reviewed analysis of the MK-677 (ibutamoren) and diphenhydramine interaction, covering CNS depression overlap, anticholinergic burden, metabolic effects, and monitoring recommendations.
Read clinical reviewCan you take MK-677 (ibutamoren) with finasteride? Review the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment guidance for this combination.
Read clinical reviewCan you take MK-677 (ibutamoren) with levothyroxine? Learn about the pharmacokinetic and pharmacodynamic interactions, thyroid monitoring needs, and clinical guidance for combining these compounds.
Read clinical reviewA clinical review of the pharmacodynamic interaction between MK-677 (ibutamoren) and metformin, covering glucose metabolism effects, monitoring protocols, and evidence-based risk assessment.
Read clinical reviewA physician-reviewed analysis of the MK-677 (ibutamoren) and NSAID interaction, covering GI, renal, and metabolic overlap risks with monitoring and dose-adjustment guidance.
Read clinical reviewClinical analysis of the MK-677 (ibutamoren) and opioid (oxycodone, hydrocodone, tramadol) interaction including CNS depression risk, CYP3A4 overlap, monitoring parameters, and dose-adjustment strategies.
Read clinical reviewCan you take MK-677 (ibutamoren) with a PPI like omeprazole or pantoprazole? Review the pharmacokinetic overlap, CYP3A4 considerations, glucose monitoring, and clinical guidance for this combination.
Read clinical reviewA clinician-reviewed analysis of the pharmacodynamic interaction between MK-677 (ibutamoren) and prednisone, covering glucose dysregulation, bone density concerns, immunosuppression overlap, and monitoring protocols.
Read clinical reviewCan you take MK-677 (ibutamoren) with pregabalin? Learn about the pharmacodynamic overlap, sedation risk, metabolic effects, monitoring requirements, and dose-adjustment strategies for this combination.
Read clinical reviewA clinical review of the MK-677 (ibutamoren) and rivaroxaban drug interaction, covering CYP3A4 and P-glycoprotein overlap, bleeding risk, GH-mediated coagulation changes, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewClinical analysis of the MK-677 and SNRI drug interaction, covering pharmacokinetic overlap, blood pressure effects, serotonin-adjacent risks, CYP3A4 metabolism, and monitoring protocols.
Read clinical reviewCan you take MK-677 (ibutamoren) with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic interaction profile, serotonin syndrome risk, blood sugar effects, and clinical monitoring recommendations.
Read clinical reviewA clinical review of the MK-677 (ibutamoren) and tadalafil drug interaction, covering CYP3A4 metabolism overlap, pharmacodynamic risks, blood pressure effects, and monitoring recommendations.
Read clinical reviewClinical review of the MK-677 (ibutamoren) and testosterone interaction, covering pharmacodynamic overlap, safety monitoring, polycythemia risk, lipid effects, and evidence-based dosing guidance.
Read clinical review